NM_000051.4:c.4768C>T

Variant summary

Our verdict is Uncertain significance. The variant received 2 ACMG points: 3P and 1B. PM1PP3BP6

The NM_000051.4(ATM):​c.4768C>T​(p.Leu1590Phe) variant causes a missense change. The variant allele was found at a frequency of 0.000127 in 1,610,480 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. L1590R) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00018 ( 0 hom., cov: 31)
Exomes 𝑓: 0.00012 ( 1 hom. )

Consequence

ATM
NM_000051.4 missense

Scores

5
10
3

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:11B:6

Conservation

PhyloP100: 5.11

Publications

14 publications found
Variant links:
Genes affected
ATM (HGNC:795): (ATM serine/threonine kinase) The protein encoded by this gene belongs to the PI3/PI4-kinase family. This protein is an important cell cycle checkpoint kinase that phosphorylates; thus, it functions as a regulator of a wide variety of downstream proteins, including tumor suppressor proteins p53 and BRCA1, checkpoint kinase CHK2, checkpoint proteins RAD17 and RAD9, and DNA repair protein NBS1. This protein and the closely related kinase ATR are thought to be master controllers of cell cycle checkpoint signaling pathways that are required for cell response to DNA damage and for genome stability. Mutations in this gene are associated with ataxia telangiectasia, an autosomal recessive disorder. [provided by RefSeq, Aug 2010]
ATM Gene-Disease associations (from GenCC):
  • ATM-related cancer predisposition
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • hereditary breast carcinoma
    Inheritance: AD Classification: DEFINITIVE Submitted by: Ambry Genetics
  • ataxia telangiectasia
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, ClinGen, Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics, Laboratory for Molecular Medicine
  • prostate cancer
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • sarcoma
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • gastric carcinoma
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • hereditary nonpolyposis colon cancer
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 2 ACMG points.

PM1
In a hotspot region, there are 3 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 1 benign, 30 uncertain in NM_000051.4
PP3
MetaRNN computational evidence supports a deleterious effect, 0.799
BP6
Variant 11-108293469-C-T is Benign according to our data. Variant chr11-108293469-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 181961.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000051.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATM
NM_000051.4
MANE Select
c.4768C>Tp.Leu1590Phe
missense
Exon 31 of 63NP_000042.3
ATM
NM_001351834.2
c.4768C>Tp.Leu1590Phe
missense
Exon 32 of 64NP_001338763.1Q13315

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATM
ENST00000675843.1
MANE Select
c.4768C>Tp.Leu1590Phe
missense
Exon 31 of 63ENSP00000501606.1Q13315
ATM
ENST00000452508.7
TSL:1
c.4768C>Tp.Leu1590Phe
missense
Exon 32 of 64ENSP00000388058.2Q13315
ATM
ENST00000531525.3
TSL:1
c.4437-1458C>T
intron
N/AENSP00000434327.3H0YDU7

Frequencies

GnomAD3 genomes
AF:
0.000178
AC:
27
AN:
152084
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.000189
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000353
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000128
AC:
32
AN:
250352
AF XY:
0.000111
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000186
Gnomad NFE exome
AF:
0.000247
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000122
AC:
178
AN:
1458396
Hom.:
1
Cov.:
30
AF XY:
0.000123
AC XY:
89
AN XY:
725732
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33386
American (AMR)
AF:
0.00
AC:
0
AN:
44672
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26082
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39516
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86130
European-Finnish (FIN)
AF:
0.000169
AC:
9
AN:
53188
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5664
European-Non Finnish (NFE)
AF:
0.000146
AC:
162
AN:
1109516
Other (OTH)
AF:
0.000116
AC:
7
AN:
60242
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.461
Heterozygous variant carriers
0
8
16
25
33
41
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000178
AC:
27
AN:
152084
Hom.:
0
Cov.:
31
AF XY:
0.000135
AC XY:
10
AN XY:
74282
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41402
American (AMR)
AF:
0.00
AC:
0
AN:
15252
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5204
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4830
European-Finnish (FIN)
AF:
0.000189
AC:
2
AN:
10578
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.000353
AC:
24
AN:
68032
Other (OTH)
AF:
0.00
AC:
0
AN:
2086
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.512
Heterozygous variant carriers
0
2
3
5
6
8
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000310
Hom.:
0
Bravo
AF:
0.0000604
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.000206
AC:
25
EpiCase
AF:
0.000327
EpiControl
AF:
0.00

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
2
2
Hereditary cancer-predisposing syndrome (4)
-
3
1
not provided (4)
-
2
1
Ataxia-telangiectasia syndrome (3)
-
2
1
Familial cancer of breast (3)
-
1
1
not specified (2)
-
1
-
Ataxia-telangiectasia syndrome;C0346153:Familial cancer of breast (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.31
BayesDel_addAF
Uncertain
0.019
T
BayesDel_noAF
Pathogenic
0.20
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Benign
0.25
T
Eigen
Pathogenic
0.75
Eigen_PC
Pathogenic
0.73
FATHMM_MKL
Uncertain
0.96
D
LIST_S2
Benign
0.83
T
M_CAP
Uncertain
0.28
D
MetaRNN
Pathogenic
0.80
D
MetaSVM
Uncertain
0.029
D
MutationAssessor
Uncertain
2.6
M
PhyloP100
5.1
PrimateAI
Uncertain
0.59
T
PROVEAN
Uncertain
-3.7
D
REVEL
Uncertain
0.48
Sift
Pathogenic
0.0
D
Sift4G
Uncertain
0.0040
D
Polyphen
1.0
D
Vest4
0.85
MVP
0.95
MPC
0.61
ClinPred
0.88
D
GERP RS
5.3
Varity_R
0.47
gMVP
0.54
Mutation Taster
=25/75
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs35962982; hg19: chr11-108164196; API